Josephine Bruce - 01 Jun 2023 Form 3 Insider Report for Rain Oncology Inc.

Role
Principal Fin. & Acc. Officer
Signature
/s/ Ryan A. Murr, Attorney-in-fact for Josephine Bruce
Issuer symbol
N/A
Transactions as of
01 Jun 2023
Net transactions value
$0
Form type
3
Filing time
09 Jun 2023, 16:05:23 UTC
Next filing
11 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RAIN Common Stock 4,588 01 Jun 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RAIN Stock Option (Right to Buy) 01 Jun 2023 Common Stock 9,723 $5.15 Direct F3
holding RAIN Stock Option (Right to Buy) 01 Jun 2023 Common Stock 5,000 $12.01 Direct F4
holding RAIN Stock Option (Right to Buy) 01 Jun 2023 Common Stock 625 $6.25 Direct F5
holding RAIN Stock Option (Right to Buy) 01 Jun 2023 Common Stock 2,450 $9.59 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 313 restricted stock units ("RSUs") that vest with respect to one-sixth at the end of each six-month period following August 30, 2022, subject to the Reporting Person's continued service to the Issuer.
F2 Consists of 1,250 RSUs that vest with respect to one-sixth at the end of each six-month period following February 14, 2023, subject to the Reporting Person's continued service to the Issuer.
F3 This option represents a right to purchase a total of 9,723 shares of the Issuer's common stock, one quarter of which vested on February 23, 2022, with the remaining three quarters vesting in equal monthly installments over three years, subject to the Reporting Person's continued service to the Issuer.
F4 This option represents a right to purchase a total of 5,000 shares of the Issuer's common stock, one quarter of which vested on January 7, 2023, with the remaining three quarters vesting in equal monthly installments over three years, subject to the Reporting Person's continued service to the Issuer.
F5 This option represents a right to purchase a total of 625 shares of the Issuer's common stock, one quarter of which will vest on August 30, 2023, with the remaining three quarters vesting in equal monthly installments over three years, subject to the Reporting Person's continued service to the Issuer.
F6 This option represents a right to purchase a total of 2,450 shares of the Issuer's common stock, one quarter of which will vest on February 14, 2024, with the remaining three quarters vesting in equal monthly installments over three years, subject to the Reporting Person's continued service to the Issuer.

Remarks:

Exhibit 24 - Power of Attorney